View More Recent Stories
-
Halozyme Therapeutics (HALO) Tops Q2 EPS by 15c ; Offers Guidance
-
H.C. Wainwright Reiterates Buy Rating on Halozyme Therapeutics (HALO)
-
H.C. Wainwright Reiterates Buy Rating on Halozyme Therapeutics (HALO)
-
Halozyme Therapeutics (HALO) PT Raised to $60 at Benchmark
-
H.C. Wainwright Reiterates Buy Rating on Halozyme Therapeutics (HALO)

